Skip to main content
. 2023 Sep 12;14:5603. doi: 10.1038/s41467-023-41376-6

Fig. 1. Generation of mRNA-based vaccine.

Fig. 1

A The structure of LASV particle. B LASV L (green and yellow) and S (purple and multi-color for the GPC) segments. C SDS PAGE gel image of in vitro transcribed prefusion and wild-type LASC GPC vaccine constructs. This was run once. D Animal study outline: schedule for two doses of vaccine, challenge, and end of study. Each group included 5 animals, for a total of 25 animals in the study. The animals were 4–6 weeks old and had a starting weight of 350–400 g. The control group received two doses of sterile phosphate-buffered saline. Graphics were generated by N. Lloyd with Biorender.com and Microsoft PowerPoint.